COMPARE · Data as of August 21, 2026
ADUS vs OPCH
Verdict: Side-by-side breakdown using the Bull Rankings model. ADUS scored 74.8, OPCH scored 76.2 — OPCH leads.
Compare another set
Different reporting periods. ADUS's fundamentals are as of June 2026, but OPCH's are as of March 2026 — a 3-month gap. Growth, margin and valuation figures below therefore describe different windows and aren't strictly like-for-like.
ADUS
Addus HomeCare Corporation
74.8
$120.55 · $2.3B
fundamentals as of
Score gap
1.4
OPCH leads
OPCH
Option Care Health, Inc.
76.2
$23.49 · $3.5B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
- CheapestOPCH17.8x
- Fastest growthOPCH+16.2%
- Strongest balance sheetADUS0.09
- Highest qualityOPCH62 / 100
- Largest discount to fair valueOPCH-35%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
The model, pillar by pillar (0–100 each)
ADUS
stronger →← stronger
OPCH
59
Qualityreturns · margins · balance sheet
62
90
Growthrevenue & earnings expansion
90
79
Valuevaluation vs sector peers
80
OPCH is stronger on 1 of 3 pillars.
Fundamentals, head-to-head
ADUS
OPCH
$155mC
FCF
$213mC
+15.9%B+
Rev
+16.2%B+
0.09B+
D/E
1.01C
21.1xB+
P/E
17.8xA-
1.10B+
PEG
1.25B
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
Valuation · DCF cross-check
ADUS
OPCH
19% below
Price vs fair valuelower is cheaper
35% below
~0%/yr
Growth the price implies10-yr FCF · lower = less priced in
~-3%/yr
+17%
1-yr DCF upside
+38%
+23%
5-yr DCF upside
+53%
+32%
10-yr DCF upside
+78%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
ADUS
No notable signals flagged.
OPCH
Why this score
- Buying back stock
The companies
ADUSAddus HomeCare Corporation
Why now
Medical Care Facilities · market cap $2.3b. 3% off the 52-week high of $124.44. Revenue growing +16%, comfortably above the S&P median. 13 sell-side analysts rate this a Buy with a mean 1-yr target of $134.69 (implying +12% upside).
Moat
FCF converts 147% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.
OPCHOption Care Health, Inc.
Why now
Medical Care Facilities · market cap $3.5b. Down 36% from 52-week high of $36.80 — deep drawdown territory. Revenue growing +16%, comfortably above the S&P median. 12 sell-side analysts rate this a Buy with a mean 1-yr target of $28.58 (implying +22% upside).
Moat
ROE 15% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. FCF converts 103% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Down 36% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Net margin 4.1% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
Verdict — model-derived comparison
OPCH leads ADUS by 1.4 points (76.2 to 74.8), its sharpest advantage coming in P/E (grade A-). A contrarian could still prefer ADUS, which trades about 19% below our DCF fair value — a margin of safety the score doesn't reward.
Our AI analyst is busy right now, so this verdict is drawn directly from the pillars, grades and DCF above.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.